UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934*
(Amendment No. ___)
Bio-Imaging Technologies, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $0.00025 per share
--------------------------------------------------------------------------------
(Title of Class of Securities)
09056N103
--------------------------------------------------------------------------------
(CUSIP Number)
May 8, 2003
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed: [ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Person Authorized to Receive Notices and Communications:
Jacob D. Smith, Esq.
Haynes and Boone, LLP
901 Main Street, Suite 3100
Dallas, Texas 75202
(214) 651-5174
SCHEDULE 13G
------------------- -----------------
CUSIP No. 09056N103 Page 2 of 6 Pages
------------------- -----------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
The Pinnacle Fund, L.P., a Texas limited partnership
75-2512784
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OR ORGANIZATION
Texas
--------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
SHARES 547,900
BENEFICIALLY ---------------------------------------------------------
OWNED BY 6 SHARED VOTING POWER
EACH
REPORTING 0
PERSON ---------------------------------------------------------
WITH 7 SOLE DISPOSITIVE POWER
547,900
---------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
547,900
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.3%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
PN
--------------------------------------------------------------------------------
------------------- -----------------
CUSIP No. 09056N103 Page 3 of 6 Pages
------------------- -----------------
Item 1(a) Name of Issuer:
Bio-Imaging Technologies, Inc.
Item 1(b) Address of Issuer's Principal Executive Offices:
826 Newtown-Yardley Road
Newtown, Pennsylvania 18940-1721
Item 2(a) Name of Person Filing:
The Pinnacle Fund, L.P.
Item 2(b) Address of Principal Business Office:
4965 Preston Park Blvd.
Suite 240
Plano, Texas 75093
Item 2(c) Citizenship:
Texas
Item 2(d) Title of Class of Securities:
Common Stock, $0.00025 per share
Item 2(e) CUSIP No:
09056N103
------------------- -----------------
CUSIP No. 09056N103 Page 4 of 6 Pages
------------------- -----------------
Item 3 Status of Person Filing:
(a) [ ] Broker or dealer registered under section 15 of
the Act (15 U.S.C. 78o);
(b) [ ] Bank as defined in section 3(a)(6) of the Act (15
U.S.C. 78c);
(c) [ ] Insurance company as defined in section 3(a)(19)
of the Act (15 U.S.C. 78c);
(d) [ ] Investment company registered under section 8 of
the Investment Company Act of 1940 (15 U.S.C.
80a-8);
(e) [ ] An investment adviser in accordance with Section
240.13d-1(b)(1)(ii)(E);
(f) [ ] An employee benefit plan or endowment fund in
accordance with Section 240.13d-1(b)(1)(ii)(F);
(g) [ ] A parent holding company or control person in
accordance with Section 240.13d-1(b)(1)(ii)(G);
(h) [ ] A savings association as defined in Section 3(b)
of the Federal Deposit Insurance Act (12 U.S.C.
1813);
(i) [ ] A church plan that is excluded from the definition
of an investment company under section 3(c)(14) of
the Investment Company Act of 1940 (15
U.S.C. 80a-3);
(j) [ ] Group, in accordance with Section
240.13d-1(b)(1)(ii)(J).
Item 4 Ownership:
(a) This statement is filed on behalf of The Pinnacle
Fund, L.P. As of May 15, 2003, The Pinnacle Fund,
L.P. was the beneficial owner of 547,900 shares of
common stock of Bio-Imaging Technologies, Inc.
(b) Percent of Class: 6.3%.
(c) Number of shares as to which each person has:
(i) sole power to vote or to direct the vote:
547,900
(ii) shared power to vote or to direct the vote:
0
(iii) sole power to dispose or to direct the
disposition of: 547,900
(iv) shared power to dispose or to direct the
disposition of: 0
------------------- -----------------
CUSIP No. 09056N103 Page 5 of 6 Pages
------------------- -----------------
Item 5 Ownership of 5% or Less of a Class:
Not applicable.
Item 6 Ownership of More than 5% on Behalf of Another Person:
Not applicable.
Item 7 Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent Holding
Company or Control Person:
Not applicable.
Item 8 Identification and Classification of Members of the Group:
Not applicable.
Item 9 Notice of Dissolution of Group:
Not applicable.
Item 10 Certification:
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired
and are not held for the purpose of or with the effect of
changing or influencing the control of the issuer of the
securities and were not acquired and are not held in
connection with or as a participant in any transaction having
that purpose or effect.
------------------- -----------------
CUSIP No. 09056N103 Page 6 of 6 Pages
------------------- -----------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: May 16, 2003
THE PINNACLE FUND, L.P.
By: Pinnacle Advisors, L.P., its general partner
By: /s/ Barry M. Kitt
---------------------------------------------
Barry M. Kitt, its general partner